Cronos Announces Extension of Share Repurchase Program to the Toronto Stock Exchange

• Cronos Group Inc. filed and received Toronto Stock Exchange (TSX) acceptance for a Normal Course Issuer Bid (NCIB) to facilitate its previously approved $50 million share repurchase program.
• The company secured an Ontario Securities Commission exemption to repurchase shares on U.S. marketplaces (NASDAQ) beyond standard Canadian limits, allowing up to 5% of outstanding shares or 10% of public float.
• Repurchases will commence on June 19, 2026, and continue until May 13, 2027.
• Daily volume limits on the TSX are capped at 53,968 shares per trading day, representing 25% of the 6-month average daily trading volume.
• Execution agents Celadon Financial Group, LLC and Virtu Canada Corp. have been appointed to manage Canadian and U.S. trades at prevailing market prices.

• This announcement is a procedural execution step for the $50 million buyback authorized on May 14, 2026, following the Q1 2026 earnings release.
• It introduces no new financial metrics, strategic pivots, or capital allocation changes.
• The $50 million cap represents approximately 6% of the company's $821.9 million cash balance, indicating a disciplined, non-dilutive approach to capital management.
• The stock price has already absorbed the initial buyback announcement, and this regulatory filing is a standard compliance milestone rather than a market-moving catalyst.

• Cronos Group Inc. is a global cannabis company focused on premium brands and international expansion.
• Core brands include Spinach® (Canada), PEACE NATURALS® (Israel), and Lord Jones® (international).
• The company operates a "borderless product strategy," leveraging high-quality genetics, R&D, and brand IP across flower, pre-rolls, edibles, and vapes.
• Key markets include Canada, Israel, and emerging European markets, with a strategic acquisition of CanAdelaar B.V. in the Netherlands pending to establish a foothold in Europe's largest adult-use market.